Thursday, 27 December 2018

Global Non-Lethal Biochemical Weapons Market Projected To Reach US$2.32 Bn By The End Of 2024

Researchmoz added Most up-to-date research on "Global Non-Lethal Biochemical Weapons Market Projected To Reach US$2.32 Bn By The End Of 2024" to its huge collection of research reports.

Interest of military forces and law enforcement agencies in non-lethal biochemical weapons has witnessed tremendous development in the recent past as progress in technology in science has appeared to provide the assurance of innovative non-lethal weapons, used in a wide variety of militarily and politically threatening situations. These weapons, also known as less than lethal biochemical weapons, intend to be less probable for killing living targets than traditional firearms or knives. These devices are specialized munitions which use chemicals calibrated to inflict injury or harm to human beings, and organisms or pathogens to cause disease. These pathogens may include viruses, bacteria, toxins or fungi.
Global Non-Lethal Biochemical Weapons Market – Key Trends and Opportunities
Rising defense expenditure by the governments of economies that are considered emerging, such as India, China, Turkey and South Korea, is projected to provide many development opportunities for the stakeholders in the global non-lethal biochemical weapons market space. Besides, the increasing research and development within this field is anticipated to boost the growth prospects of these weapons during the forecast period.
However, the development of the non-lethal biochemical weapons can be impacted by certain definite restraining factors in the near future. These restraints include a decline in the defense budget of developed countries, and stringent governmental and environmental regulations.


The opportunities of demand in the global non-lethal biochemical weapons market are the result of different incidents of civil conflicts and unrest in South Asia, the Middle East, and the North African regions. These zones have been recognized as highly dynamic markets for non-lethal biochemical weapons, because of the exponential rates of demand growth in the recent past. For instance, the sectarian unrest in Lebanon, the Syrian civil war, and the political viciousness in Jerusalem call for enhanced response by the military as well as law enforcement agencies. As a consequence, the securing of non-lethal biochemical weapons by military forces is expected to rise substantially during the forecast period. Thus the dynamic global market for these weapons has high potential. So the opportunities of the market could be accredited to the transforming political and regional dynamics of the world economy, rising incidences of armed terrorism and violence.
Global Non-Lethal Biochemical Weapons Market – Key Market Segments
Based on the various non-lethal biochemical weapons operations, the global market is segmented into defensive, offensive, and genetic attack. Swift growth in demand for genetic attack weapons is a major factor to boost the demand for non-lethal biochemical weapons, globally. On the basis of product type, this market is segmented into directed energy weapons (DEW), and direct contact weapons. Non-lethal biochemical weaponry in the directed energy segment has accounted for an astounding pace of consolidation, because of giant industrial conglomerates taking over smaller organizations rapidly. With respect to end use, the global non-lethal biochemical weapons market can be segmented into law enforcement agencies and military forces.


Global Non-Lethal Biochemical Weapons Market – Regional Outlook
By geography, the global non-lethal biochemical Weapons market has been classified into five regions namely North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. Currently, the Middle East and Africa segment held the major share of the market, followed by North America, Asia Pacific, Europe, and Latin America. The Asia Pacific region is expected to develop rapidly with rising trade with North America and Europe. Regional players have been focusing on partnerships with players in regions such as Africa.
Global Non-Lethal Biochemical Weapons Market – Vendor Landscape
The leading manufacturing companies profiled in this report are BAE Systems, Inc.; Lamperd Less Lethal, Inc., Taser International, Inc.; Raytheon Company; Textron Systems, Corp.; General Dynamics Corporation; Chemring Group PLC.; Moog, Inc; Qinetiq Group, Inc.; and LRAD Corporation. These organizations focus on evolving innovative products after investment of substantial amount of their net sales in research and development for introducing progressive technologies with large range abilities, reduced weight, and relatively higher precision.
The segments covered in the Non-Lethal Biochemical Weapons market are as follows:
Global Non-Lethal Biochemical Weapons Market: By Operation Type
  • Defensive
  • Offensive
  • Genetic Attack
Global Non-Lethal Biochemical Weapons Market: By Product Type
  • Directed Energy
  • Direct Contact
Global Non-Lethal Biochemical Weapons Market: By End Use
  • Military Forces
  • Law Enforcement Agencies
Global Non-Lethal Biochemical Weapons Market: By Geography
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
  • Middle East and Africa

U.S. Lighting Products Market Is Poised To Exhibit A CAGR Of 5.0% Between The Forecast Period 2014 - 2024

Researchmoz added Most up-to-date research on "U.S. Lighting Products Market Is Poised To Exhibit A CAGR Of 5.0% Between The Forecast Period 2014 - 2024" to its huge collection of research reports.

The U.S. lighting products market report provides analysis for the period 2014–2024, wherein the period from 2016 to 2024 is the forecast and 2015 is the base year. The report highlights the major trends and developments playing influential role in the U.S. lighting product market’s growth over the forecast period. It also highlights the driver, restraint, and opportunity expected to impact market’s growth during the said period. The study provides a complete perspective on the U.S. lighting product market’s evolution throughout the mentioned forecast period in terms of revenue and volume (in US$ Bn and Bn Units).
This report provides all the essential information required to understand the key developments in in the U.S., growth trend of each segment and companies’ strategies to efficiently compete in the market. Also, the report provides insights related to volume of lighting fixtures and bulbs sold in the U.S. (in Bn units) and the estimated volume of the lighting products in the forecast period. Furthermore, Porter’s Five Forces analysis explains the factors which are currently affecting the lighting product market This report also provides the value chain analysis for the lighting product market which explains the participants of the value chain and the shift in how these interact with changing dynamism.
U.S. Lighting Products Market: Scope of the Report
The market overview section of the report demonstrates the market dynamics such as the driver, restraint, and opportunity that influence the current nature and future status of this market, key indicators and trends. An attractiveness analysis has also been provided for every segment in the report, in order to give a thorough understanding of the overall scenario for the U.S. lighting product market. Moreover, the report provides an overview of the various strategies adopted by key players present in the market. Key market indicators included in the report provide significance of the factors which are capable of changing the market scenario. These indicators are expected to define the market growth during the forecast period.


U.S. Lighting Product Market: Key Segments
The report segments the market on the basis of standalone type that includes LED Tubes & Bulbs, T8 LED tubes & bulbs and Others (Incandescent, High Intensity Discharge). The market is also segmented on the basis of lighting fixture to include ceiling fixtures, recessed lighting fixture, strip light fixture and others (chandeliers, pendants, etc.). The application of these lighting products are considered in various areas such as residential, commercial, industrial and outdoor. The outdoor application of lighting includes garage parking, landscape and streetlight. The report provides in-depth segment analysis of the U.S. market, thereby providing valuable insights at the macro as well as micro levels.
U.S. Lighting Product Market: Competitive Landscape
The report also highlights the competitive landscape of the U.S. product lighting market, thereby positioning all the major players according to their presence in the U.S. and recent key developments initiated by them in lighting product market. The comprehensive lighting product market estimates are the result of our in-depth secondary research, primary interviews, and in-house expert panel reviews. These market estimates have been analyzed by taking into account the impact of different political, social, economic, technological, and legal factors along with the current market dynamics affecting the U.S. lighting product market growth.
The Home Depot, Lowes, Target, Wal-Mart, Bed Bath & Beyond, Sam's Club, Costco, Menards are some of the major players operating within the U.S. lighting product market profiled in this study. Details such as financials, SWOT analysis, business strategies, recent developments, and other such strategic information pertaining to these players have been duly provided as part of the company profiling.


The U.S. Lighting Product Market
By Product
  • By Standalone Type
  • LED Tubes & Bulbs
  • T8 LED tubes & bulbs
  • Others(Incandescent, High Intensity Discharge)
  • By Lighting Fixture
  • Ceiling Fixtures
  • Recessed Lighting Fixture
  • Strip Light Fixture
  • Others (Chandeliers, Pendants, etc.)
By Application
  • Residential Lighting
  • Table Lamp
  • Floor Lamp
  • Desk Lamp
  • Others
  • Commercial Lighting
  • Industrial Lighting
  • Outdoor Lighting (Street Lights, Parking Garage, Landscape, etc.) 
By Retailers
  • The Home Depot
  • Lowes
  • Target
  • Wal-Mart
  • Bed Bath & Beyond
  • Sam's Club
  • Costco
  • Menards

Global Gastrointestinal Drugs Market Growth Is Prophesized To Occur At A Healthy CAGR Of 4.90% During The Forecast Period 2016 - 2024

Researchmoz added Most up-to-date research on "Global Gastrointestinal Drugs Market Growth Is Prophesized To Occur At A Healthy CAGR Of 4.90% During The Forecast Period 2016 - 2024" to its huge collection of research reports.

Global Gastrointestinal Drugs Market
Gastro esophageal reflux disease (GERD), inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are types of gastrointestinal disease. gastro esophageal reflux disease (GERD) is a chronic gastric illness that arises when acidic juices in the stomach come back up into the esophagus from stomach, this can leads to irritation of esophagus and causes symptoms like heartburn, gas, etc. Inflammatory bowel disease is a group of chronic inflammation of small and large intestine. Ulcerative Colitis and Crohns disease are the two major types of inflammatory bowel disease. Irritable bowel syndrome (IBS) is a chronic condition that affects the colon (large intestine). Diarrhea, constipation, abdominal pain, cramping are the common symptoms of irritable bowel disease.

The market overview section of the report comprises qualitative analysis of the overall gastrointestinal drugs market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porters five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis for the drug class, route of administration, drug class, distribution channel, and key industry developments has also been provided. Key industry developments include the major events occurred in past 4-5 years and are expected to occur during the forecast period which are likely to affect the market dynamics.


Global Gastrointestinal Drugs Market: Segmentation

The global gastrointestinal drugs market has been segmented on the basis of drug class, route of administration, drug class, distribution channel. On the basis of drug class the global gastrointestinal drugs market is segmented into acid neutralizers, antidiarrheal and laxatives, antiemetic and antinauseants, anti-inflammatory drugs, biologics and others including antispasmodic etc. The acid neutralizer segment is again segmented as antacids, H2 antagonists and Proton pump inhibitors. On the basis of route of administration, the global gastrointestinal drugs market has been segmented into three types such as, oral, parenteral and rectal. Based on disorder type, the global gastrointestinal drugs market is segmented into gastro esophageal reflux disease, inflammatory bowel disease and Irritable bowel syndrome. On the basis of distribution channel, the global gastrointestinal drugs market is segmented as hospital pharmacies, retail pharmacies and online pharmacies.

The market for these drug class, route of administration, disorder type, and distribution channel has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, and geographic presence and product developments. The market size and forecast in terms of revenue (US$ million), for each of these segments, and the sub-segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.


Geographically, the gastrointestinal drugs market has been classified into five segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size forecast for each region has been provided for the period 2014 to 2024, in terms of drug class, route of administration, disorder type, and distribution channel, along with the CAGR (%) for the forecast period 2016 to 2024.

Global Gastrointestinal Drugs Market: Competitive Analysis

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global gastrointestinal drugs market, in terms of percentage share in 2016 (estimated) has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

The report concludes with the profiles of major players in the global gastrointestinal drugs market such as Takeda pharmaceutical, Valeant Pharmaceuticals International, Inc., Janssen Biotech, Inc., Bayer AG, Sanofi, AstraZeneca, Allergan Plc, GlaxoSmithKline, Abbott Laboratories, Boehringer Ingelheim GmbH and Allergan Plc., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global gastrointestinal drugs market is segmented as follows:

By Drug Class

  • Acid Neutralizers
  • Antacids
  • H2 antagonists
  • Proton pump inhibitors
  • Antidiarrheal and Laxatives
  • Antiemetic and Antinauseants
  • Anti-inflammatory drugs
  • Biologics
  • Others (Antispasmodic etc.)
By Route of Administration
  • Oral
  • Parenteral
  • Rectal
By Disorder Type
  • Gastro Esophageal Reflux Disease
  • Inflammatory Bowel Disease
  • Irritable Bowel Syndrome
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico

ResearchMoz: Growing Demand For Optic Nerve Disorders Drug Development Pipeline Review, 2018

Researchmoz added Most up-to-date research on "ResearchMoz: Growing Demand For Optic Nerve Disorders Drug Development Pipeline Review, 2018" to its huge collection of research reports.

Optic Nerve Disorders Drug Development

This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve fibers that transmits visual information from the eye to the brain. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for optic neuropathy, glaucoma, Lebers hereditary optic neuropathy (LHON) and optic neuritis, and features dormant and discontinued products.
Optic neuropathy is an inherited form of vision loss. Symptoms include eye pain or discomfort, numbness, tingling and clouding of vision. There are 10 products in development for this indication.

Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. Signs and symptoms include eye pain, nausea and vomiting (accompanying the severe eye pain), sudden onset of visual disturbance, often in low light, blurred vision and reddening of the eye. There are 13 products in development for this indication.


LHON is an inherited form of vision loss. This condition usually begins in a persons teens or twenties. Males are affected much more often than females. Symptoms include eye pain or discomfort, numbness, tingling and clouding of vision. There are 16 products in development for this indication.

Optic neuritis refers to inflammation of the optic nerve. Symptoms include pain, vision loss, dyschromatopsia (impaired ability to perceive colors) and flashing lights. There are 12 products in development for this indication.

Molecular targets acted on by products in development for optic nerve disorders include kinases, growth factors and cannabinoid receptors. Companies operating in this pipeline space include NicOx SA Regeneron Pharmaceuticals and Amgen.


Scope

  • - Which companies are the most active within each pipeline?
  • - Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • - To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • - What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Present Scenario And Growth Prospects Of Hereditary Hematological Disorders Drug Development Pipeline Review, 2018

Researchmoz added Most up-to-date research on "Present Scenario And Growth Prospects Of Hereditary Hematological Disorders Drug Development Pipeline Review, 2018" to its huge collection of research reports.

This report provides an overview of the pipeline landscape for hereditary hematological disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for thalassemia, hemophilia B and sickle cell anemia, and features dormant and discontinued products.
Thalassemia refers to a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include paleness, frequent infections and jaundice. Predisposing factors include family history. Treatment includes blood transfusions and bone marrow transplant. There are 40 products in development for this indication.

Hemophilia B is a hereditary bleeding disorder caused by a lack of blood clotting factor IX. Symptoms include bleeding into joints and associated pain and swelling, bruising, nosebleeds and prolonged bleeding from injuries and surgery. Treatment includes replacing the defective clotting factor. There are 42 products in development for this indication.

Sickle cell anemia is a genetic blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. Treatment includes antibiotics, pain relievers, blood transfusion and stem cell transplant. There are 68 products in development for this indication.


Molecular targets acted on by products in development for hereditary hematological disorders include coagulation factors, histone deacetylases and protein kinases. Companies operating in this pipeline space include Sangamo Therapeutics, Gamida Cell and Bluebird Bio.

Scope

  • Which companies are the most active within each pipeline?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?


Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Deep Research Report On Global Seafood Processing Machinery Market: Emerging Trends and Opportunities to 2025

Researchmoz added Most up-to-date research on "Deep Research Report On Global Seafood Processing Machinery Market: Emerging Trends and Opportunities to 2025" to its huge collection of research reports.

This report presents the worldwide Seafood Processing Machinery market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The Seafood Processing Machinery market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Seafood Processing Machinery.

The following manufacturers are covered in this report:
GRANDBELL
Marel
GEA Group
Manitowoc Company
YANAGIYA
Baader
Optimar Fodema
United Food & Beverage
Bettcher
Neofood
Guangdong Peninsula Group

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1929059

Seafood Processing Machinery Breakdown Data by Type
Fish Processing Machinery
Shrimp Processing Machinery
Shellfish and Algae Processing Machinery
Others

Seafood Processing Machinery Breakdown Data by Application
Application 1
Application 2

Seafood Processing Machinery Production by Region
United States
Europe
China
Japan
Other Regions

Seafood Processing Machinery Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

Browse TOC @ https://www.researchmoz.us/global-seafood-processing-machinery-market-insightsforecast-to-2025-report.html/toc

The study objectives are:
To analyze and research the global Seafood Processing Machinery status and future forecastinvolving, production, revenue, consumption, historical and forecast.
To present the key Seafood Processing Machinery manufacturers, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Seafood Processing Machinery :
History Year: 2013 - 2017
Base Year: 2017
Estimated Year: 2018
Forecast Year: 2018 - 2025

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Seafood Processing Machinery market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Aircraft Engine Market Highly Growing in Global Industry - General Electric, Rolls-Royce Holdings, United Technologies Corporation and Safran SA

Researchmoz added Most up-to-date research on "Aircraft Engine Market Highly Growing in Global Industry - General Electric, Rolls-Royce Holdings, United Technologies Corporation and Safran SA" to its huge collection of research reports.

This report presents the worldwide Aircraft Engine market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The Aircraft Engine market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Aircraft Engine.

The following manufacturers are covered in this report:
General Electric
Rolls-Royce Holdings
United Technologies Corporation
Textron, Inc
Safran SA
Honeywell International
CFM International SA
International Aero Engines AG
Engine Alliance LLC
MTU Aero Engines AG

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1929061

Aircraft Engine Breakdown Data by Type
Turboprop Engine
Turbofan Engine
Turboshaft Engine
Piston Engine

Aircraft Engine Breakdown Data by Application
Civil Aviation
Military Aviation

Aircraft Engine Production by Region
United States
Europe
China
Japan
Other Regions

Aircraft Engine Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

Browse TOC @ https://www.researchmoz.us/global-aircraft-engine-market-insightsforecast-to-2025-report.html/toc

The study objectives are:
To analyze and research the global Aircraft Engine status and future forecastinvolving, production, revenue, consumption, historical and forecast.
To present the key Aircraft Engine manufacturers, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Aircraft Engine :
History Year: 2013 - 2017
Base Year: 2017
Estimated Year: 2018
Forecast Year: 2018 - 2025

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Aircraft Engine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.